Published online May 2, 2016. doi: 10.5314/wjd.v5.i2.93
Peer-review started: September 16, 2015
First decision: October 27, 2015
Revised: March 16, 2016
Accepted: April 7, 2016
Article in press: April 11, 2016
Published online: May 2, 2016
Core tip: Vitiligo is a procured depigmentation issue with great effect on patient’s appearance and his satisfaction. Till date, the etiology of vitiligo remains elusive, which makes it difficult to have curative therapies. Narrowband ultraviolet B (UVB) phototherapy is generally utilized and delivers great clinical results. In this manuscript, I review the excursion of narrowband UVB from its prior days of advancement until this time as monotherapy, its comparison with psoralen and ultraviolet A and other modes of phototherapy and in combination with other therapies in the management of vitiligo.